KRRO (Korro Bio) Stock Based Compensation: $8.63 Mil (TTM As of Mar. 2026)


KRRO Korro Bio Inc KRRO
6 GF Score
Price $14.49
! 5 Warning Signs
View Full Analysis

What is Korro Bio Stock Based Compensation?

Korro Bio KRRO +3.24% 6 Stock Based Compensation is $8.63 Mil as of Mar. 2026. GuruFocus rates KRRO with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

Korro Bio's Stock Based Compensation for the three months ended in Mar. 2026 was $2.73 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $8.63 Mil.

Korro Bio Stock Based Compensation Related Terms

Korro Bio Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Korro Bio's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korro Bio Stock Based Compensation Chart

Korro Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
0.81 1.14 2.38 4.46 7.66

Korro Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 2.00 1.83 2.07 2.73
KRRO
6GF Score
Korro Bio Inc KRRO
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Korro Bio Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.63 Mil.

What does a Stock Based Compensation of $8.63 Mil mean?
Korro Bio (KRRO) has a Stock Based Compensation of $8.63 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Korro Bio and its competitors.
Is Korro Bio's Stock Based Compensation too high?
Korro Bio's current Stock Based Compensation is $8.63 Mil. Overall, Korro Bio has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Korro Bio's Stock Based Compensation compare to LENZ and ANTX?
Korro Bio's Stock Based Compensation of $8.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Korro Bio and its competitors. Korro Bio's current Stock Based Compensation is $8.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korro Bio stock overvalued right now?
Korro Bio (KRRO) has a current Stock Based Compensation of $8.63 Mil. The current Stock Based Compensation is $8.63 Mil. Korro Bio's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Korro Bio (KRRO), the current Stock Based Compensation is $8.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Korro Bio Business Description

Address 60 First Street, 2nd Floor, Suite 250, Cambridge, MA, USA, 02141
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
6GF Score

Get the complete analysis for KRRO

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.49
Price